The UroLift™ System

The #1 chosen minimally invasive BPH procedure in the U.S.1 Treat a broad spectrum of anatomies with confidence.8,9

Contact a Urology Consultant

Let’s Get Real

Real data integrity. Real safety. Real durability.
See the Data

Safety

Lowest rate of complications at one year when compared to both minimally invasive and invasive procedures.*2

Efficacy

Effective alternative to drug therapy without heating, cutting, or removing prostate tissue.3

Durability

Proven, durable results3 as shown by Healthcare Claims and Utilization Analysis and L.I.F.T. Study.

 

Redefining Minimally Invasive BPH Treatment

More than 14 million men are treated for BPH/LUTS in the U.S. but only 2% elect to undergo a BPH procedure.1 
The UroLift™ System is a proven option for patients seeking an alternative to BPH medications.3

Treat a Broad Spectrum of Anatomies with Confidence8,9

The UroLift™ System uses a straightforward approach to treating BPH that lifts and holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. It can be used to treat a broad spectrum of anatomies, including obstructive median lobe and prostates up to 100cc.8,9 It is the only leading BPH treatment that does not require heating, cutting or destruction of the prostate tissue.5,7
Learn About the Procedure
Treatment with the UroLift™ System does not preclude future UroLift™ System treatments, TURP, or laser procedures.3

UroLift™ Delivery Devices and Implants

Contact a Urology Consultant

Now it’s easier to treat a broader spectrum of BPH patients, including lateral and median lobe hyperplasia, with the full line of UroLift™ products.8,9

Contact a Urology Consultant

UroLift™ 2 System

Inserted transuretherally through a rigid sheath under cystoscopic visualization to reach the targeted area of obstruction. Typically one Delivery Handle is used per procedure, and individual Implant Cartridges deliver each UroLift™ Implant.

 

Learn about UroLift 2 System

UroLift ATC™ System

The UroLift™ Advanced Tissue Control System allows physicians to confidently treat more patients by enhancing control of tissue and optimizing accuracy with the same, proven implant.

 

Learn about UroLift ATC System

UroLift™ Implant

The obstructing prostatic lobes are held apart by small UroLift™ Implants that are deployed by the delivery device. Each implant is made with common implantable materials: nitinol, stainless steel, and PET suture.+ Typically, four to six implants are placed into the prostate.

 

Learn about the UroLift Implant

Patient Selection

The UroLift™ System provides consistant outcomes to a broad range of BPH patients.10
Prostate Indications for the UroLift™ System✝
Minimum prostate volumeNone
Maximum prostate volume100 cc
Obstructive median lobeYes
The UroLift™ System should not be used if the patient has:
  • Prostate volume of >100 cc
  • A urinary tract infection
  • Urethral conditions that may prevent insertion of a delivery system into the bladder
  • Urinary incontinence due to incompetent sphincter
  • Current gross hematuria

475,000

BPH patients have been treated with the UroLift™ System11

How BPH Treatment Options Stack Up

The treatment plan you and your patients decide on will likely be influenced by many factors, including quality of life, importance of certain activities, potential side effects, and level of risk involved.   

See how typical BPH treatment options align with common treatment goals. Which goals are most important to you and your patients? 

Compare Treatments
    MAC02259-05 Rev A, p.5